Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1832526 (
PCC
)
5,967
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The presence of
argininosuccinate lyase
(
ASL
), an enzyme catalyzing the final step of arginine biosynthesis, was demonstrated in the heterocystous cyanobacterium Nostoc
PCC
73102 by measuring in vitro enzyme activity and by visualization of
ASL
in native protein gels. Activity staining of a native PAGE gel revealed one
ASL
-dependent band with a molecular mass of about 240 kDa. A colorimetric assay for
ASL
based on the measurement of urea produced from arginine in the presence of an excess of arginase was further used to analyze the cyanobacterial
ASL
. The in vitro
ASL
activity was highest in cells in exponential growth phase and decreased significantly during the stationary phase of growth, ranging from 4.4 to 0.8 nmol of product formed (mg protein)-1 min-1. Including arginine, citrulline or ornithine in the growth medium resulted in no significant change in the
ASL
activities, indicating that Nostoc
PCC
73102
ASL
is not regulated by metabolites of the ornithine cycle.
...
PMID:Ornithine cycle in Nostoc PCC 73102: presence of an in vitro functional argininosuccinate lyase. 922 73
A gene argH, encoding
argininosuccinate lyase
(
ASL
), has been cloned from a cosmid library of the filamentous cyanobacterium Nostoc sp. strain
PCC
73102. The argH open reading frame encodes a protein comprised of 461 amino acids with a calculated molecular mass of 51,349 Da. Protein sequence comparisons reveal significant similarities of the Nostoc
PCC
73102
ASL
to related proteins from other organisms. In an Escherichia coli delta argH strain, the Nostoc
PCC
73102
ASL
expressed from a recombinant plasmid could restore the ability to grow on medium without arginine. Moreover, cell extracts show a specific
ASL
activity of 16.2 nmoles of urea x min(-1) x (mg protein)(-1). Partially purified, His-tagged
ASL
runs as a 53-kDa protein band in SDS-PAGE and about 215-kDa protein in native-PAGE, suggesting that the native protein is a tetramer.
...
PMID:Cloning, characterization, and functional expression in Escherichia coli of argH encoding argininosuccinate lyase in the cyanobacterium Nostoc sp. strain PCC 73102. 1168 60
Cyanophycin (multi-l-arginyl-poly-l-aspartic acid; also known as cyanophycin grana peptide [CGP]) is a putative precursor for numerous biodegradable technically used chemicals. Therefore, the biosynthesis and production of the polymer in recombinant organisms is of special interest. The synthesis of cyanophycin derivatives consisting of a wider range of constituents would broaden the applications of this polymer. We applied recombinant Saccharomyces cerevisiae strains defective in arginine metabolism and expressing the cyanophycin synthetase of Synechocystis sp. strain
PCC
6308 in order to synthesize CGP with citrulline and ornithine as constituents. Strains defective in arginine degradation (Car1 and Car2) accumulated up to 4% (wt/wt) CGP, whereas strains defective in arginine synthesis (Arg1, Arg3, and Arg4) accumulated up to 15.3% (wt/wt) of CGP, which is more than twofold higher than the previously content reported in yeast and the highest content ever reported in eukaryotes. Characterization of the isolated polymers by different analytical methods indicated that CGP synthesized by strain Arg1 (with argininosuccinate synthetase deleted) consisted of up to 20 mol% of citrulline, whereas CGP from strain Arg3 (with ornithine carbamoyltransferase deleted) consisted of up to 8 mol% of ornithine, and CGP isolated from strain Arg4 (with
argininosuccinate lyase
deleted) consisted of up to 16 mol% lysine. Cultivation experiments indicated that the incorporation of citrulline or ornithine is enhanced by the addition of low amounts of arginine (2 mM) and also by the addition of ornithine or citrulline (10 to 40 mM), respectively, to the medium.
...
PMID:Metabolic engineering of Saccharomyces cerevisiae for production of novel cyanophycins with an extended range of constituent amino acids. 1934 56